MultiCell, which develops therapeutics for the treatment of degenerative neurological diseases, metabolic and endocrinological disorders, and infectious diseases, raised $1.7 million in gross proceeds in a private placement
The Roche-supported study, named PERSIST, involved 103 primary care centers across the UK, with 1,076 women each agreeing to participate for a six-month period. In the study, 542
A review of 12 studies carried out by the Cochrane Collaboration found that a 1.5g dose of calcium by mouth during the second half of pregnancy significantly reduced
The fast track designation for Nexavar (sorafenib) tablets in advanced (including locally unresectable and metastatic) melanoma means Bayer and Onyx will be able to file a new drug
The delay is due to the fact that Pfizer wants to introduce Exubera after conducting a comprehensive physician and patient education and training program. To further support patients
Under the terms of the agreement, Amgen has the right to develop drug candidates it has identified from Infinity’s compound collection. Infinity received an upfront license fee from
NeoProfen (ibuprofen lysine) injection 10mg/mL is indicated – when usual medical management is ineffective – to close a clinically significant patent ductus arteriosus (PDA), a condition in which
The company reported net income for the second quarter of 2006 of $37.2 million compared with $26 million in the second quarter of last year. Diluted earnings per
Net sales for the second quarter increased to $228 million compared with $196.4 million in the second quarter of 2005. Diluted earnings per share for the three months
The three-month placebo-controlled clinical trial, which GTx initiated in May, is evaluating multiple doses of ostarine in 60 elderly men and 60 postmenopausal women. It is designed to
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.